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Termination translation in Saccharomyces cerevisiae is controlled by two interacting polypeptide chain release 
factors, eRF1 and eRF3. Two regions in human eRF1, position at 281-305 and position at 411-415, were proposed 
to be involved on the interaction to eRF3. In this study we have constructed and characterized yeast eRF1 mutant 
at position 410 (correspond to 415 human eRF1) from tyrosine to serine residue resulting eRF1(Y410S). The mu-
tations did not affect the viability and temperature sensitivity of the cell. The stop codons suppression of the 
mutant was analyzed in vivo using PGK-stop codon-LACZ gene fusion and showed that the suppression of the 
mutant was significantly increased in all of codon terminations. The suppression on UAG codon was the highest 
increased among the stop codons by comparing the suppression of the wild type respectively. In vitro interaction 
between eRF1 (mutant and wild type) to eRF3 were carried out using eRF1-(His)6 and eRF1(Y410S)-(His)6 ex-
pressed in Escherichia coli and indigenous Saccharomyces cerevisiae eRF3. The results showed that the binding af-
finity of eRF1(Y410S) to eRF3 was decreased up to 20% of the wild type binding affinity. Computer modeling 
analysis using Swiss-Prot and Amber version 9.0 programs revealed that the overall structure of eRF1(Y410S) has 
no significant different with the wild type. However, substitution of tyrosine to serine triggered the structural 
change on the other motif of C-terminal domain of eRF1. The data suggested that increasing stop codon sup-
pression and decreasing of the binding affinity of eRF1(Y410S) were probably due to the slight modification on 
the structure of the C-terminal domain. 
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INTRODUCTION 
Protein biosynthesis is a complex phenomenon 
involving RNA-RNA, RNA-protein and pro-
tein-protein interactions. This process is carried out in 
three distinct steps: initiation, elongation and termina-
tion. While the first two steps have been extensively 
studied, our understanding of the termination process 
has lagged behind.   
Protein biosynthesis terminates when one of the 
three stop codons enters the aminoacyl site (A-site) 
and signals polypeptide chain release from the pepti-
dyl-tRNA located in the ribosomal P-site [1]. The 
process is facilitated by two general groups of acces-
sory proteins: a class I release factor, codon-specific 
RFs (RF1 and RF2 in prokaryotes; eRF1 in eukaryotes), 
and a class II release factor, codon-non specific RFs 
(RF3 in prokaryotes and eRF3 in eukaryotes) that binds 
guanine nucleotides-binding proteins possessing 
GTPase activity [2, 3, 4]. Although the basic biological 
action of class-1 RFs is similar between prokaryotes 
and eukaryotes, they exhibit distinct structural and 
functional features. Yeast eukaryotic release factor 1 
(eRF1) encoded by SUP45 gene, recognizes any of the 
three stop codons [5]. Eukaryotic release factor 3 
(eRF3) in yeast encoded by SUP35 gene, stimulates the 
termination reaction in GTP dependent manner [6, 4]. 
Following stop codon recognition, eRF1 also induces 
polypeptide chain release by activating peptidyl 
transferase center of the ribosome. 
Both eRF1 and eRF3 are essential for viability of 
yeast cells and deletion of the C-terminal part of each 
protein separately lead to lethality [1]. Crystal struc-
ture of human eRF1 has been determined and found 
that the protein is composed by three domains. The 
N-terminal domain (domain1) has been proposed to be 
responsible for stop codon recognition [7]. This pro-
posal was supported by mutational approach [5] and 
crosslinking experiment [8]. The middle domain (do-
main 2) is responsible for peptidyl transferase hydro-
lytic activity and includes a GGQ motif that has been 
highly conserved through evolution [9]. Mutations in 
GGQ (Gly residues) are dominant-negative in vitro Int. J. Biol. Sci. 2008, 4 
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and lethal in vivo in S. cerevisiae cells [7]. The domain 3 
corresponds to the C-terminal part of eRF1 that is 
necessary for the interaction with eRF3 although there 
are discrepancies in the precise location of the region 
of eRF1 that interacts with eRF3. Progressive deletion 
of the C-terminal of eRF1, 6-19 amino acids in S. cere-
visiae [10] and 17 amino acids of Schizosaccharomyces 
pombe [2] resulted in a corresponding loss of eRF3 
binding. In any case, the core eRF3-binding region 
identified for Homo sapiens eRF1 (by the yeast 
two-hybrid and deletion analysis), showed that two 
regions in each release factor are critical for mutual 
binding, position 281-305 and 411-415 (GILRY) of eRF1 
and position 478-530 and 628-637 of eRF3 (11]. Al-
though deletion of residues within domain 3 of eRF1 
resulted in the loss of eRF3 interaction, however detail 
position and amino acid residues for the interaction 
are still unclear yet. 
Preliminary study using computer modeling 
analysis on the structure of yeast eRF1, especially on 
the above two regions showed that tyrosine at position 
of 410 (Y410) and threonine at position of 295 (T295) of 
eRF1 exposed to the surface of molecules. Tyrosine at 
position of 410 is one of amino acid residues in 
AMLRY (GILRY like) motif of yeast eRF1 protein. 
Among of the amino acid residues on the AMLRY 
motif, tyrosine is one of best possible amino acid resi-
dues that contributing on its interaction since this 
residues containing hydroxyl group. In order to probe 
the role of tyrosine at AMLRY motif (Y410) of eRF1, 
here we reported the effect of mutation Y410 on the 
termination of protein biosynthesis. The nonsense 
codon suppressions have been used to assay the accu-
racy of termination process.  
MATERIALS AND METHODS 
Microbial strains, plasmids and growth conditions.  
S. cerevisiae strains used in this study are listed in 
Table 1. All strains were SUQ5 and [psi-]. Yeast cul-
tures were growth in standard rich medium, YPD (1% 
(w/v) bacto peptone, 0.5% (w/v) yeast extract, and 2% 
(w/v) glucose); Y8 (1% (w/v) bacto peptone, 0.5% 
(w/v) yeast extract, and 8% (w/v) glucose) or minimal 
m e d i u m  w a s  u s e d  S M  ( 0 . 6 7 %  ( w / v )  y e a s t  n i t r o g e n  
base, 2% (w/v) glucose, supplemented with appropri-
ate amino acids) at 300C with gently shaking. For the 
plasmid shuffling, the strains were grown on medium 
YNB-FOA (0.67 % (w/v) yeast nitrogen base, 2% (w/v) 
glucose, 0.1% (w/v) 5-Fluorootic acid (5-FOA), 20 
μg/mL uracil). 
Plasmid pUKC1901, a shuttle vector between E. 
coli and S. cerevisiae cells, carrying sup45-Y410S gene 
was used for construction of other plasmids and 
∆LE2-Y410S strain. The other plasmid, pUKC815, 817, 
818, and 819 were used for nonsense codon 
readthrough assay on S. cerevisiae. All plasmids named 
by pUKC (Table 2) were gift from M.F. Tuite, Univer-
sity of Kent, United Kingdom. 
Table 1. Yeast strains used in this study. 
Strains   Genotype  
Yeast ΔLE2(803)  SUQ5, ade2-1,his3-11,15, ura3-1, leu2-1, 
can1-100, [psi-], SUP45::HIS3 
Yeast ΔLE2(SUP45)  SUQ5, ade2-1,his3-11,15, ura3-1, leu2-1, 
can1-100, [psi-], SUP45::HIS3, [LEU2-1-SUP45 
wild-type]  
Yeast ΔLE2(Y410S)  SUQ5, ade2-1,his3-11,15, ura3-1, leu2-1, 
can1-100, [psi-], SUP45::HIS3, 
[LEU2-1-sup45-Y410S]  
Table 2. Plasmid used in this study. 
Plasmid Description 
pUKC630  E. coli expression vector carrying SUP45 gene 
with a hexa-histidine sequence under the 
control of T7 RNA polymerase promoter.  
pEPES-Y410S  Similar plasmid with pUKC630 that SUP45 
was replaced by sup45-Y410S 
pUKC1901  S. cerevisiae LEU2 based plasmid carrying the 
sup45-Y410S 
pSPES-SUP45 
 
Similar plasmid with pUKC1901 that 
sup45-Y410S gene was replace by SUP45 
pUKC606  Multicopy yeast vector carrying SUP35 gene 
with original promoter 
pUKC815  S. cerevisiae URA3 based plasmid carrying the 
PGK-LACZ gene fusion. 
pUKC817  S. cerevisiae URA3 based plasmid carrying the 
PGK-TAA- LACZ gene fusion. 
pUKC818  S. cerevisiae URA3 based plasmid carrying the 
PGK-TAG- LACZ gene fusion. 
pUKC819  S. cerevisiae URA3 based plasmid carrying the 
PGK-TGA- LACZ gene fusion. 
Plasmid Constructions.  
Two plasmids, namely pSPES-SUP45, and 
pEPES-Y410S were constructed in this study. To gen-
erate plasmids pSPES-SUP45, a 1400 bp BglII-HindIII 
fragments from plasmid pUKC630 containing the en-
tire SUP45 gene was cloned into BglII and BamHI sites 
of plasmid pUKC1901, a shuttle vector of E. coli and S. 
cerevisiae. While plasmid pEPES-Y410S was con-
structed using 1400 bp of HindIII-BglII fragment from 
plasmid pUKC1901 ligated into HindIII and BglII re-
striction sites of plasmid pUKC630. All of the plasmids 
were used to transform E. coli DH5α for propagating 
the plasmid. 
Plasmid Shuffling.  
The plasmid shuffling was carried out based on 
the standard method [12]. The haploid ∆LE2(803) 
(SUP45::HIS3,  URA3,  SUP45) was used in plasmid 
shuffling. The strain was transformed with (LEU2 
sup45) plasmids (pSPES-SUP45 and pUKC1901). The 
transformants were selected on medium without uracil 
and leucine ( –Ura –Leu) and then checked by repli-
cating onto 5-FOA medium to counter selects against 
URA3 plasmids. Growth was also assayed using serial 
dilution overnight culture with OD600 = 1. Serially Int. J. Biol. Sci. 2008, 4 
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(10-fold) diluted yeast cell cultures were spotted on 
plates containing 5-FOA to determine the ability of 
sup45 mutant alleles to support cell growth. The wild 
type of yeast SUP45 gene carried on URA3 plasmid 
eliminates since 5-FOA is toxic to cell expressing the 
URA3 gene. The resulting strains, ∆LE(SUP45) and 
∆LE(Y410S), were used for further characterization. 
β-galactosidase assays.  
Centromeric plasmids pUKC815, 817, 818 and 819 
[13] were transformed into suppressor strains 
(∆LE(SUP45), and ∆LE(Y410S)). The transformants 
were grown in plasmid-selective medium and 3 X 106 
cells were inoculated into 5 mL YPD respectively. 
Triplicate samples from cultures grown to OD600 ~ 1.0 
were treated essentially as described by Coligan et al. 
[14], with the following modifications. The cells were 
suspended in 500 µL Z buffer, 10 µL 0.1% SDS and 20 
µL chloroform. The samples were then vortexed for 15 
s and equilibrated for 15 min in a 30oC water bath. 
After adding 100 µL 4 mg/mL O-nitrophenyl- 
β-D-galactosidase (ONPG), samples were vortexed for 
5 s and the reaction were carried out for 30 min at 30oC 
water bath before stopping the reaction by adding 500 
µL 1M sodium carbonate. After centrifugation at 5000 
g, the supernatants were measured at both 420 nm and 
550 nm wavelengths and the Miller unit of each sam-
ples were calculated as (OD420) – (OD550 x 1.75). The 
readthrough for each of the three stop codons was 
calculated as the percentage of LacZ expression rela-
tive to the construct lacking a stop codon (pUKC815) in 
the same medium. 
Expression of yeast eRF1-(His)6 and 
eRF1(Y410S)-(His)6 in E. coli.  
The recombinant plasmid, pUKC630 and 
pEPES-Y410S containing His-tag gene at the upstream 
region of SUP45 or sup45-Y410S coding sequences 
were introduced into E. coli BL2(DE3) as host strain for 
eRF1 expression system. For expression of the gene, 
the transformants were grown aerobically at 370C in 
LB containing ampicillin until the cells density reached 
2x108  cell/mL or OD600 at around 0.6. The cultures 
were induced by addition of 0.1 mM IPTG and incu-
bated at 250C for 4 h with aeration. The cultures were 
then centrifuged at 5000 g and the pellets were 
re-suspended in solubilization buffer (50mM Tris-HCl 
pH 7.4; 200 mM NaCl). Lysis cells were performed by 
sonication. The samples were centrifuged at 10000 g 
and analyzed by sodium dodecyl sulfate polyacryla-
mid gel electrophoresis (SDS-PAGE). The SDS-PAGE 
was performed with a 12.5% (w/v) acrylamide gel, 
and the proteins were stained with commassie blue 
G-250 [15]. 
Preparation of yeast post-mitochondrial super-
natants (PMS).  
Yeast cultures were grown to a cell density of 3.5x 
107 cells/ml. Harvested cells were washed with lysis 
buffer (25 mM Tris-HCl, pH 7.2, 5 mM MgCl2, 5 mM 
2-mercaptoethanol and 25 mM KCl) containing 1 mM 
phenylmethylsulphonyl fluoride (PMSF), 1 mM ben-
zamidine, 10 µM leupeptin and 10 µM pepstatin A to 
limit proteolytic degradation. Following washing in 
lysis buffer, harvested cells were resuspended in a 
minimum volume of the same buffer. Cells were lysed 
by vortexing with glass beads and cell debris removed 
by centrifugation at 13 000 rpm for 15 min in a bench-
top microcentrifuge, producing a postmitochondrial 
supernatant (PMS).  
Immobilization of eRF1-(His)6.  
The following operations were performed at 
room temperature unless otherwise stated and col-
umns were allowed to flow by gravity. A 500 µL col-
umn of Ni-NTA resin (Qiagen) was equilibrated with 
30 mM bis-Tris-HCl, pH 6.8, 0.8 M KCl, 5 mM 
2-mercaptoethanol, 30 mM imidazole (buffer A). E. coli 
crude extract containing eRF1-(His)6 and 
eRF1(Y410S)-(His)6 were passed three times through 
the resins separately, which were then washed with 10 
column vol. buffer A followed by 10 vol. buffer con-
taining 30 mM bis-Tris-HCl, pH 6.2, 1 M KCI, 5 mM 
2-mercaptoethanol, 20% glycerol, 30 mM imidazole. 
This procedure resulted in partial purification and 
immobilization of eRF1-(His)6 and eRF1(Y410S)-(His)6 
on the Ni-NTA resins. In order to assess the binding of 
eRF3 to the immobilized eRF1-(His)6 and 
eRF1(Y410S)-(His)6, the resins were equilibrated with 
10 column vol. lysis buffer containing 25 mM KCI. A 
PMS prepared from cells overexpressing eRF3 (trans-
formed with plasmid pUKC606) was then incubated 
with a suspension of the resin in 25 mM KCI lysis 
buffer for 2 h on a shaking platform at 4°C. After this 
time the resin was centrifuged briefly, the supernatant 
removed and retained and the resins returned to col-
um n s fo r w a sh in g w it h  1 0 c o l um n  v o l. 2 5 m M K C I 
lysis buffer containing 0.15% w/v Tween-20 detergent. 
Computer modelling.  
The initial three dimensional structure of eRF1 
was constructed by homology protein structure mod-
eling from Swiss-Prot using predict protein program 
[16]. The comparative modeling program used three 
steps: alignment of amino acid sequence of yeast eRF1 
with the template of human eRF1 [7], PDB number 
1DT9.pdb., structure prediction based on primary se-
quences homology, and validation of the structure 
using WHAT_IF program in Swiss-Prot. 
  Amber version 9.0 program package [17] was Int. J. Biol. Sci. 2008, 4 
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used for the molecular simulation. The structure was 
subjected to energy minimization calculation by 
steepest descent method with 500 iterations followed 
by the conjugate gradient method with 4500 iteration 
to be used as starting lowest energy structure. Simula-
tion image of the protein was generated using Visual 
Molecular Dynamic (VMD) software [18]. The Root 
Mean Square Deviation (RSMD) was calculated for the 
backbone atoms with reference to starting structure of 
time 0. 
RESULTS 
Construction characterization of yeast strains, 
∆LE2(SUP45) and ∆LE2(Y410S).  
∆LE2(SUP45) and ∆LE2(Y410S) are haploid yeast 
strains that carrying chromosomal SUP45 disrupted by 
HIS3 gene (SUP45::HIS3),  SUP45 and sup45 gene in 
plasmid pSEPES-SUP45 and pUKC1901 respectively. 
The strains were constructed from ∆LE2(803), haploid 
strain which carrying SUP45::HIS3 and SUP45 gene in 
CEN URA3 based plasmid. ∆LE2(803) strain was 
transformed with LEU2 based plasmid carrying SUP45 
or sup45-Y410S mutant. The transformants were then 
subjected to plasmid shuffle analysis to verify weather 
strains containing sup45-Y410S could lose the viability 
(Fig 1A). Transformants carrying sup45-Y410S allele 
and SUP45 (as control) were able to grow in the pres-
ence of 5-FOA, indicating that all tested mutation can 
replace the wild type of SUP45 for the viability (data 
not show). However, plasmid shuffle was less efficient 
with sup45 mutants than with the wild type SUP45. 
 
 
 
 
Figure 1. Shuffling strategy and the phenotype of the transformants. A. Strategy used for plasmid shuffling. (1), LEU2 based 
plasmid was introduced to ∆LE2(803). (2), double transformant was iduced on media containing 5-FOA. B. Phenotypes of trans-
formants. ∆LE2(SUP45) and ∆LE2(Y410S) grown on rich medium (Y8), SM medium without leucine (-Leu), SM medium without 
uracil (-Ura). 
 
  The viable transformants on media containing 
5-FOA were characterized, including genotypes, tem-
perature sensitivity and the allosuppressor phenotypes 
to UAA codon in ade2-1 gene. All of viable cells carry-
ing SUP45 and sup45-Y410S could grow on rich me-
dium (Y8) and synthetic medium without leucine 
(-Leu), however unable to grow on synthetic medium 
without uracil (-Ura) (Fig 1B). The viability of the 
transformants on media –Leu and unviable on media 
without uracil showed that URA3 based plasmid had 
been replaced by LEU2 based plasmid. The data con-
firmed that the plasmid shuffling had been success-
fully carried out. On rich medium (Y8), the color of 
transformants carrying wild type SUP45 gene ap-
peared pink color, while transformants carrying mu-
tation on sup45-Y410S showed white color (Fig 1B). 
This indicating, that sup45-Y410S exhibited allosup-
pressor phenotype. Furthermore, none of the trans-Int. J. Biol. Sci. 2008, 4 
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formants showed temperature sensitive mutants (data 
not shown). 
Efficiency of ∆LE2(Y410S) on stop codon suppres-
sion.  
Stop codon readthrough on ∆LE2(Y410S) and 
∆LE2(SUP45) were measured based on the ability of 
the cells to terminate the translational process on fu-
sion gene between PGK-termination codon-LACZ car-
ried by centromeric (single copy), URA3 based plas-
mid [26]. The strains were transformed by each of se-
rial plasmids (pUKC815, 817, 818, and 819). Plasmid 
pUKC817, 818, and 819 carry UAA, UAG, and UGA 
termination codons respectively, while plasmid 
pUKC815 was used as control plasmid without codon 
termination. 
  The suppression of ∆LE2(Y410S) on all stop 
codons were significantly increased compared to that 
the wild type (∆LE2(SUP45)) (Fig 2). The suppression 
of ∆LE2(Y410S) on UAG codon was the highest than 
that other codons, over 17 times fold than the 
∆LE2(SUP45). While, the suppression for UGA codon 
was over 12 times higher than the wild type. Total 
suppression on UAA codon revealed the highest 
compared to that the other codons in both mutant and 
the wild type, this was not surprising since the strains 
used in this study carrying SUQ5, which is a weak 
tRNA suppressor for UAA codon, genetic background.   
 
 
Figure 2.  β- galactosidase assay for ∆LE2(SUP45) and 
∆LE2(Y410S). Vertical axis for % of suppression compared to 
β- galactosidase activity transformant carrying plasmid 
pUKC815. 
Binding Affinity of eRF1(Y410S) to eRF3.  
eRF1 has been demonstrated to interacts with 
eRF3 in vitro [19]. In order to investigate the influence 
of mutation at Y410S on the interaction to eRF3, the 
ability of eRF1(Y410S) to precipitate eRF3 was tested 
and compared to that the ability of eRF1 wild type. 
Over expression of eRF1-(His)6 and 
eRF1(Y410S)-(His)6 were carried out in E. coli BL2(DE3) 
using plasmid pUKC630 and pEPES-Y410S (Fig 3). 
Four E. coli crude extracts, two containing eRF1-(His)6 
and other containing eRF1(Y410S)-(His)6, in high salt 
concentration (0.8 M KCl) lysis buffer, were repeatedly 
passed through Ni-NTA-agarose resins separately, 
ensuring preferential binding of the His-tag proteins to 
the resins and limiting non-specific binding of other 
proteins. The majority of non-specifically bound pro-
teins were removed by washing the resins under 
stringent condition of low pH and high salt and glyc-
erol. This resulted in preparation of partially purified 
eRF1-(His)6 and eRF1(Y410S)-(His)6 bound to nickel 
resins. 
 
Figure 3. SDS-PAGE electrophoregram of crude extract of E. 
coli overexpressed eRF1-(His)6 and eRF1(Y410S)-(His)6.; It is 
in first without IPTG induction and then with IPTG induction 
for both couple of lanes 2-3 and 4-5; lanes 1 and 6 are protein 
molecular markers. 
 
In order to probe the eRF1-eRF3 interaction, the 
eRF1-(His)6 and eRF1(Y410S)-(His)6 resins were tested 
for the ability to precipitate eRF3 from solution. eRF3 
was overexpressed in yeast strain ∆LE2(803) trans-
formed with pUKC606, from which a PMS was pre-
pared. The eRF3-rich PMS was then incubated with 
either the eRF1-(His)6 resin or eRF1(Y410S)-(His)6 
resin for 2 h in a low salt buffer to promote pro-
tein-protein interactions. Both eRF1-(His)6 and 
eRF1(Y410S)-(His)6 resins were then returned to col-
umns to facilitate washing. The control resins were not 
mixed with eRF3-rich PMS. 
Samples of eRF3-rich PMS were analyzed by 
SDS-PAGE. The results showed that there was no eRF3 
detected on the control resins. While for the sample 
resins, there were some amounts of eRF3 protein. The 
eRF3 bound to eRF1(Y410S)-(His)6 was less quantity 
than that on eRF1-(His)6 (Fig 4A). Quantitative analy-
sis of eRF3 bound to the resins were carried out by 
using densitometric analysis to measure the ratio of 
eRF3 : eRF1-(His)6 and eRF3 : eRF1(Y410S)-(His)6. The Int. J. Biol. Sci. 2008, 4 
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r e s u l t  s h o w e d  t h a t  t h e  b i n d i n g  a f f i n i t y  o f  e R F 3  t o  
eRF1(Y410S)-(His)6 was 20% of the eRF3 to the wild 
type (Fig 4B).  
Structural modeling of eRF1(Y410S). 
Structural modeling of eRF1 mutant and the wild 
type were performed using Amber 9 program fol-
lowed by visualization using View Molecular Dynamic 
( V M D ) .  B a s e d  o n  t h e  R o o t  M e a n  S q u a r e  D e v i a t i o n  
(RMSD) value, the overall structure of eRF1(Y410S) 
showed no significant different compared to the wild 
type (Fig 5A). However detail analysis on the structure 
of eRF1 third domain showed that eRF1(Y410S) con-
tained secondary structure change (Fig 5 B, C). The 
structure of amino acid residues change on 
eRF1(Y410S) was not in the same motif with the posi-
tion of mutation (Fig 5C, 1), but in the other motif (Fig 
5C, 2). Comparison among the C-terminal domain of 
human eRF1 (1DT9), yeast eRF1 and eRF1(Y410S) 
showed that there was 7 amino acid residues from 
position at 343 - 349 (yeast position) changed from 
non-helix to helix forms (Fig 6). Ramanchandran Plot 
between yeast eRF1 and eRF1(Y410S) at the above po-
sition (343 - 349) revealed that the residues in 
eRF1(Y410S) tend to be more stable in helical form (Fig 
7). 
 
 
Figure 4. SDS-PAGE electrophoregram of eRF3 bound to eRF1(His)6 resin and densitometric quantitation. A. Electrophoregram of 
eRF3 bound to eRF1(His)6 resin. Lane 1 and 6, purified eRF3 carrying His tag overexpressed in yeast. Lane 2 and 3, 
eRF1-Y410S(His)6 resins with (sample) and without (control) eRF3 bound. Lane 4 and 5, eRF1(His)6 resins without (control) and 
with (sample) eRF3 bound. B. Comparison between the ratio of eRF3 : eRF1(His)6 and eRF3 : eRF1-Y410S(His)6. The ratio be-
tween eRF3 : eRF1(His)6 used as control (100%). 
 
 
Figure 5. Three dimensional structure of eRF1 
and eRF1-Y410S modelling. A. Superposition 
of eRF1 (red) and eRF1-Y410S (yellow) struc-
tures; domain 3 of eRF1 (circle). B and C. Close 
up structure of eRF1 and eRF1-Y410 domain 3; 
position of mutation (1), position of structural 
change before (B) and after (C) mutation (2, and 
3).  Int. J. Biol. Sci. 2008, 4 
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Figure 6. Homological of C-terminal among human, yeast and Y410S of eRF1. 1dt9A, human eRF1; s for beta sheet; h for helix; red 
bar showed secondary structure change; blue bar showed position of mutation. 
 
 
 
Figure 7. Ramachandran plot for 11 amino acid residues including 7 amino acid residues changed from non-helix to helix form. A 
for yeast eRF1; B for eRF1(Y410S). 
 
DISCUSSION 
Domain3 of eRF1 was proposed to be responsible 
for the interaction with eRF3 protein respectively [2, 
20, 21]. Serial deletion on t h i s  r e g i o n  h a v e  b e e n  r e -
ported to have defect on its interaction [10], however 
there was no information concerning the effect of 
amino acid substitution in the region. We have con-
structed and characterized sup45 mutant which has 
mutation in codon no 410 for tyrosine to serine. Tyro-
sine at position 415 in human eRF1 is one of the amino 
acids that are critical for mutual binding lied on GILRY 
motif of human eRF1 [11].   Int. J. Biol. Sci. 2008, 4 
 
94
SUP45 is essential gene in haploid S. cerevisiae cell 
[1]. Disruption of the gene causes lethality in haploid 
yeast cell. In order to assay mutation in the gene in 
vivo, the mutant gene was introduced to ∆LE2(803) 
which carrying disruption of chromosomal 
SUP45::HIS3 and SUP45 gene in single copy URA3 
based plasmid. The transformants containing double 
plasmid (URA3 and LEU2 based plasmids) were sub-
jected for plasmid shuffle [22] by growing the cell on 
medium containing 5-FOA. The wild type yeast SUP45 
gene carried on the URA3 plasmid eliminated because 
5-FOA is toxic to cell expressing the URA3 gene [23]. 
Mutation of sup45-Y410S showed an allosup-
pressor phenotype (Fig 1B). ∆LE2(803) carries ade2 and 
SUQ5 in addition of SUP45::HIS3 and SUP45 CEN 
URA3 based plasmid. SUQ5 is a weak tRNA suppres-
sor [24]. This tRNA suppressor does not suppress 
nonsense codon on ade2 mutant on [psi-] genetic back-
ground [25]. However, mutation on sup45 gene could 
enhance the activity of SUQ5 [26] to suppress nonsense 
mutation on ade2 gene. Mutation on sup45-Y410S en-
hanced all of stop codon suppressions (Fig 2). How-
ever the quantitative values were variation depend on 
the type of stop codons.  UAA codon was the most 
readthrough in all strains examined including the wild 
type. This was not surprising since all strains carrying 
SUQ5 genetic background. SUQ5 is codon specific 
tRNA suppressor for UAA codon [13]. While on UAG 
and UGA codons, the suppression of the wild type 
strain was very low, almost no suppression (Fig 2). 
However for the mutant strains, the suppression of 
UAG and UGA were significantly increased. The UAG 
codon was the mostly leaky codon in the mutant. This 
was unexpected since eRF1 reported to recognize all of 
stop codons in the same manner [27, 28, 6]. 
Termination translation in eukaryotic system that 
involved interaction between eRF1 and eRF3 is a com-
plex phenomenon. Detail mechanism of the process is 
still unclear yet. eRF1 was reported to be phosphory-
lated by CK2 protein but the product did not signifi-
cantly affect directly to translation termination [29]. 
Urakov  et al. [30] demonstrated that IttIp could 
modulate the efficiency of termination translation in 
yeast. Meanwhile, recent report showed that eRF1 
protein participates not only on termination transla-
tion but also in mRNA degradation and translation 
initiation via interaction with other proteins [22]. 
In order to characterize the causes of an elevation 
of suppression in sup45-Y410S, in vitro interaction of 
eRF1(Y410S) to eRF3 was examined. The result showed 
that there was significant reduction on the binding 
affinity of eRF1(Y410S) to eRF3 (Fig 4). As conse-
quences the suppressor was preferable to recognize the 
nonsense codons and thus increase the read-through. 
Further analysis on three dimensional structures of 
eRF1(Y410S) showed there was alteration on secon-
dary structure of some amino acids residues from 
non-helix to helix form (Fig 6). The structural modifi-
cation in eRF1(Y410S) did not directly affect on the 
structure of AMLRY motif but triggered structural 
modification of neighboring motifs (Fig 5C). This 
modification might affect the interaction of 
eRF1(Y410S) to eRF3 and thus increasing the suppres-
sion of codon terminations.  
The AMLRY motif lies at position 406- 410 resi-
dues of yeast eRF1 which has 437 amino acid residues. 
Amino acid substitution in the end of C- or N-terminal 
of protein usually does not affect the overall structure 
of the protein since these residues will be stabilized by 
water solvent. Substitution of tyrosine at position 410 
to serine did not significantly affect the overall struc-
ture of eRF1 but triggered alteration on the secondary 
structure of amino acid residues lied at position 
343-349. This was quite surprising since the distance of 
the residues is a far way. Tyrosine and serine both 
contained hydroxyl group, however, the proton on 
serine could not ionized while tyrosine does, in addi-
tion tyrosine contains bulky functional group and 
electron dense. These differences in electrostatic and 
electronic features might affect the probability of sec-
ondary structure of surrounding amino acid residues, 
however simulation result showed that substitution of 
tyrosine to phenylalanine did not affect the secondary 
structure of amino acid residues at the above position 
(unpublished data) so it is unlikely that the bulky 
functional group and the electron dense caused the 
structural change. The most possible explanation is 
that the differences on the properties of hydroxyl 
group was the key factor for the structural change on 
the region and thus substitution of tyrosine to serine 
reduced the energetic state and stabilized secondary 
structure to form helix (Fig 7).  
All the data obtained suggests that tyrosine at 
AMLRY motif is important amino acid residue for the 
interaction to eRF3, however the hydroxyl group of 
tyrosine seems does not directly involve on the bind-
ing to eRF3. The intact of three dimensional structure 
of domain 3 of eRF1 is suggested as a key factor for the 
interaction to eRF3. 
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